Clinical Trial Update: Fiasp® Versus NovoRapid® in Children With Type 1 Diabetes on MiniMed 640G Pump With Sensor

View source ↗

Summary

A completed clinical trial comparing the performance of Fiasp and NovoRapid in children with type 1 diabetes using a MiniMed 640G pump with sensor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Fiasp (insulin aspart)
• NovoRapid (insulin aspart)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Type 1 Diabetes | Status: COMPLETED